Bio Plus Statistics

Total Valuation

Bio Plus has a market cap or net worth of KRW 261.89 billion. The enterprise value is 254.49 billion.

Market Cap	261.89B
Enterprise Value	254.49B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Bio Plus has 56.93 million shares outstanding. The number of shares has increased by 1.49% in one year.

Current Share Class	n/a
Shares Outstanding	56.93M
Shares Change (YoY)	+1.49%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	33.70%
Owned by Institutions (%)	6.57%
Float	37.59M

Valuation Ratios

The trailing PE ratio is 13.40.

PE Ratio	13.40
Forward PE	n/a
PS Ratio	4.82
PB Ratio	2.01
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.69, with an EV/FCF ratio of -9.22.

EV / Earnings	12.72
EV / Sales	4.66
EV / EBITDA	11.69
EV / EBIT	13.47
EV / FCF	-9.22

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.04.

Current Ratio	2.58
Quick Ratio	2.05
Debt / Equity	0.04
Debt / EBITDA	0.24
Debt / FCF	-0.19
Interest Coverage	125.67

Financial Efficiency

Return on equity (ROE) is 16.38% and return on invested capital (ROIC) is 8.20%.

Return on Equity (ROE)	16.38%
Return on Assets (ROA)	7.05%
Return on Capital (ROIC)	8.20%
Revenue Per Employee	634.67M
Profits Per Employee	232.71M
Employee Count	86
Asset Turnover	0.33
Inventory Turnover	2.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.24%
50-Day Moving Average	5,308.20
200-Day Moving Average	5,989.03
Relative Strength Index (RSI)	28.20
Average Volume (20 Days)	414,790

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bio Plus had revenue of KRW 54.58 billion and earned 20.01 billion in profits. Earnings per share was 343.20.

Revenue	54.58B
Gross Profit	32.15B
Operating Income	18.89B
Pretax Income	26.42B
Net Income	20.01B
EBITDA	21.77B
EBIT	18.89B
Earnings Per Share (EPS)	343.20

Full Income Statement

Balance Sheet

The company has 31.49 billion in cash and 5.33 billion in debt, giving a net cash position of 26.16 billion or 459.50 per share.

Cash & Cash Equivalents	31.49B
Total Debt	5.33B
Net Cash	26.16B
Net Cash Per Share	459.50
Equity (Book Value)	149.10B
Book Value Per Share	2,289.32
Working Capital	35.24B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 29.69 billion and capital expenditures -57.29 billion, giving a free cash flow of -27.60 billion.

Operating Cash Flow	29.69B
Capital Expenditures	-57.29B
Free Cash Flow	-27.60B
FCF Per Share	-484.79

Full Cash Flow Statement

Margins

Gross margin is 58.90%, with operating and profit margins of 34.61% and 36.67%.

Gross Margin	58.90%
Operating Margin	34.61%
Pretax Margin	48.41%
Profit Margin	36.67%
EBITDA Margin	39.88%
EBIT Margin	34.61%
FCF Margin	-50.57%

Dividends & Yields

This stock pays an annual dividend of 70.00, which amounts to a dividend yield of 1.52%.

Dividend Per Share	70.00
Dividend Yield	1.52%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	20.97%
Buyback Yield	-1.49%
Shareholder Yield	0.04%
Earnings Yield	7.46%
FCF Yield	-10.54%

Dividend Details

Stock Splits

The last stock split was on November 23, 2022. It was a forward split with a ratio of 4.

Last Split Date	Nov 23, 2022
Split Type	Forward
Split Ratio	4

Scores

Bio Plus has an Altman Z-Score of 9.6.

Altman Z-Score	9.6
Piotroski F-Score	n/a